International pharmaceutical company governed by a non-profit foundation
This article is about the pharmaceutical company. For other uses, see Servier (disambiguation).
Servier
Company type
Private
Industry
Pharmaceutical
Founded
(1954; 70 years ago (1954))
Founder
Jacques Servier
Headquarters
Suresnes, Île-de-France
,
France
Products
Pharmaceuticals
Revenue
€4.2 billion (FY 2018)
Number of employees
22,000
Website
Official website
Footnotes / references [1][2]
Servier Laboratories (French: Laboratoires Servier, often abbreviated to Servier) is an international pharmaceutical company governed by a non-profit foundation, with its headquarters in France (Suresnes).[3]
The consolidated turnover for the 2018 financial year was €4.2 billion.[4] Servier is the leading French independent pharmaceutical company, and the second largest French pharmaceutical company. It has branches in 149 countries, achieving 82% of its sales outside France.[5][6] The company reportedly invests a little under 25% of its turnover in research and development, which occupies 3,000 of its 22,000 employees worldwide.[7] The company's production sites produced 853 million drug boxes in 2013.[5]
The Servier Clinical Support Unit in Gidy (near Orléans), which produces drugs for clinical trials, is the largest unit of its kind in Europe.[8]Servier Laboratories is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA).[9]
In 2018, Servier finalized the acquisition of Shire’s oncology branch in Boston and named David K. Lee as CEO. The official opening of Servier's new U.S. headquarters took place in 2019.[4]
In 2009, Mediator, an amphetamine-based Servier drug originally developed for weight loss in people with diabetes but often prescribed off-label as a dieting aid, was withdrawn from the market after being linked to 500–2000 deaths in France.[10][11] Further investigations found that many previous safety alerts on that drug had been either missed or covered up, possibly due to the improper influence of the company.[11]
^"Key figures". Servier. Archived from the original on 2014-10-09. Retrieved 2015-02-03.
^"History". Servier. Archived from the original on 2017-08-05. Retrieved 2015-02-03.
^"French drug maker Servier sets up US headquarters in Seaport". Boston Globe. May 9, 2019.
^ ab"Servier launches U.S. cancer business with plans to double headcount in next 5 years". Boston Business Journal. May 9, 2019.
^ ab"SERVIER - Pharmaceutical company specialized in cardiology, diabetes, rheumatology, depression". Retrieved 2007-07-08.
^"Servier and Galapagos complete enrollment of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis". Bloomberg. June 11, 2019.
^"Servier's US push takes shape as Boston HQ opens". BioPharma Dive. May 9, 2019.
^"Servier UK - Key figures". Archived from the original on 2007-07-08. Retrieved 2007-07-08.
^"The Pharmaceutical Industry in Figures - 2008 Edition". European Federation of Pharmaceutical Industries and Associations (EFPIA). p. 49. Archived from the original on 2008-09-16. Retrieved 2008-08-25.
^Article of the Figaro about Mediator
^ abUn doute sur la «sécurité» du Mediator dès 1998 - Libération
and 26 Related for: Laboratoires Servier information
Servier Laboratories (French: LaboratoiresServier, often abbreviated to Servier) is an international pharmaceutical company governed by a non-profit foundation...
Jacques Servier (9 February 1922 – 16 April 2014) was a French doctor and businessman. He was the founder and president of LaboratoiresServier, a pharmaceutical...
containing 90% diosmin and 10% hesperidin. It is manufactured by LaboratoiresServier and often used to treat or manage disorders of the blood vessels...
approval were ended in 2011. It was developed by the pharmaceutical company Servier. Agomelatine is used for the treatment of major depressive episodes in...
attributed to the diabetes drug Mediator, produced by French manufacturer LaboratoiresServier. Sidse Babett Knudsen portrays real-life whistleblower Dr. Irene...
Commission imposed fines of €427,700,000 on LaboratoiresServier and 5 companies which produce generics due to Servier's abuse of their dominant market position...
on 2015-04-16. Retrieved 2015-04-16. "Amgen and Servier announce product collaboration". www.servier.com. Archived from the original on 2016-03-04. Retrieved...
neuropsychiatry. It was established in 1999 and was originally published by LaboratoiresServier. Starting 2022, the journal is published by Taylor & Francis on behalf...
tianeptine is approved in France and manufactured and marketed by Laboratories Servier SA; it is also marketed in a number of other European countries under the...
first cytoprotective anti-ischemic agent developed and marketed by LaboratoiresServier (France). It is an anti-ischemic (antianginal) metabolic agent of...
Gliclazide, sold under the brand name Diamicron among others, is a sulfonylurea type of anti-diabetic medication, used to treat type 2 diabetes. It is...
Indapamide is a thiazide-like diuretic drug used in the treatment of hypertension, as well as decompensated heart failure. Combination preparations with...
883 (2009 to Centre National de la Recherche Scientifique CNRS, LaboratoiresServier, Universite Paris Sud (Paris 11)). Volgin, A. D., Bashirzade, A....
the 1960s. Introduced in France in 1978 by the pharmaceutical company Servier, amineptine soon gained a reputation for abuse due to its short-lived,...
entirety the approximately €12 million of debt owed by XOMA to Les LaboratoiresServier. XOMA is eligible to receive up to $438 million in development, regulatory...
being developed with rozrolimupab (Sym001) being the lead product. LaboratoiresServier acquired Symphogen in 2020. Genentech, Inc.: Collaboration pact with...
cholangiocarcinoma. The applicant for this medicinal product is Les LaboratoiresServier. Tibsovo was approved for medical use in the European Union in May...
Philippe (2008). "SERVIER - Veins of the foot - Marginal veins and their branches". Servier (phlebologia.com). LES LABORATOIRESSERVIER. Archived from the...
Philippe (2008). "SERVIER - Veins of the foot - Marginal veins and their branches". Servier (phlebologia.com). LES LABORATOIRESSERVIER. Archived from the...
Chancellor [2014] UKSC 54 22 October 2014 Jurisdiction [330] Les LaboratoiresServier v Apotex Inc [2014] UKSC 55 29 October 2014 Ex turpi causa [331]...
the Fédération nationale de la mutualité française [fr] against LaboratoiresServier (Mediator scandal) and the one of the European Parliament against...
Global Information